Oral Topical Cyclo-oxygenase2 Inhibitors (COX2-1) mouthwash for the treatment of oral dysplasia - a proof of concept study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin (Primary)
- Indications Oropharyngeal cancer; Oropharyngeal dysplasia
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms ASPOD; INHANSE-ASPOD
Most Recent Events
- 12 Aug 2013 Biomarkers information updated
- 09 Aug 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01238185).
- 14 Feb 2012 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network.